These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 27141440)
1. Clinical significance of serum Protease-Activated Receptor-1 (PAR-1) levels in patients with cutaneous melanoma. Tas F; Bilgin E; Karabulut S; Erturk K; Duranyildiz D BBA Clin; 2016 Jun; 5():166-9. PubMed ID: 27141440 [TBL] [Abstract][Full Text] [Related]
2. Clinical significance of serum protease-activated receptor-1 levels in gastric cancer patients. Tas F; Karabulut S; Tastekin D; Duranyildiz D Biomed Rep; 2016 Apr; 4(4):489-492. PubMed ID: 27073639 [TBL] [Abstract][Full Text] [Related]
3. Serum transforming growth factor-beta 1 (TGF-β1) levels have diagnostic, predictive, and possible prognostic roles in patients with melanoma. Tas F; Karabulut S; Yasasever CT; Duranyildiz D Tumour Biol; 2014 Jul; 35(7):7233-7. PubMed ID: 24771267 [TBL] [Abstract][Full Text] [Related]
4. Clinical significance of serum caveolin-1 levels in melanoma patients. Tas F; Karabulut S; Tilgen Yasasever C; Duranyildiz D Int J Dermatol; 2016 May; 55(5):558-62. PubMed ID: 26084616 [TBL] [Abstract][Full Text] [Related]
5. Clinical Significance of Circulating Serum Cellular Heat Shock Protein 90 (HSP90) Level in Patients with Cutaneous Malignant Melanoma. Tas F; Bilgin E; Erturk K; Duranyildiz D Asian Pac J Cancer Prev; 2017 Mar; 18(3):599-601. PubMed ID: 28440609 [TBL] [Abstract][Full Text] [Related]
6. Serum transforming growth factor-beta1 levels may have predictive and prognostic roles in patients with gastric cancer. Tas F; Yasasever CT; Karabulut S; Tastekin D; Duranyildiz D Tumour Biol; 2015 Mar; 36(3):2097-103. PubMed ID: 25391430 [TBL] [Abstract][Full Text] [Related]
7. Clinical Significance of Serum Galectin-3 Levels in Gastric Cancer Patients. Tas F; Bilgin E; Tastekin D; Erturk K; Duranyildiz D J Gastrointest Cancer; 2016 Jun; 47(2):182-6. PubMed ID: 27038444 [TBL] [Abstract][Full Text] [Related]
8. Circulating annexin A2 as a biomarker in gastric cancer patients: correlation with clinical variables. Tas F; Tilgen Yasasever C; Karabulut S; Tastekin D; Duranyildiz D Biomed Pharmacother; 2015 Feb; 69():237-41. PubMed ID: 25661364 [TBL] [Abstract][Full Text] [Related]
9. Clinical significance of serum laminin and type-IV collagen levels in cutaneous melanoma patients. Tas F; Bilgin E; Karabulut S; Duranyildiz D Mol Clin Oncol; 2016 Jul; 5(1):195-200. PubMed ID: 27330797 [TBL] [Abstract][Full Text] [Related]
10. Clinical significance of serum claudin-1 levels in melanoma patients. Tas F; Bilgin E; Erturk K; Duranyildiz D Melanoma Res; 2016 Aug; 26(4):377-81. PubMed ID: 26886788 [TBL] [Abstract][Full Text] [Related]
11. Clinical significance of serum fibronectin and vitronectin levels in melanoma patients. Tas F; Karabulut S; Bilgin E; Tastekin D; Duranyildiz D Melanoma Res; 2014 Oct; 24(5):475-9. PubMed ID: 24999757 [TBL] [Abstract][Full Text] [Related]
12. Levels of serum fibronectin as a biomarker in gastric cancer patients: Correlation with clinical diagnosis and outcome. Tas F; Bilgin E; Karabulut S; Tastekin D; Duranyildiz D Mol Clin Oncol; 2016 Apr; 4(4):655-659. PubMed ID: 27073685 [TBL] [Abstract][Full Text] [Related]
13. Clinical significance of serum epidermal growth factor receptor (EGFR) levels in patients with breast cancer. Tas F; Bilgin E; Karabulut S; Duranyildiz D Cytokine; 2015 Jan; 71(1):66-70. PubMed ID: 25259789 [TBL] [Abstract][Full Text] [Related]
14. Clinical significance of serum interleukin-18 (IL-18) levels in patients with gastric cancer. Tas F; Tilgen Yasasever C; Karabulut S; Tastekin D; Duranyildiz D Biomed Pharmacother; 2015 Mar; 70():19-23. PubMed ID: 25776473 [TBL] [Abstract][Full Text] [Related]
15. Clinical significance of serum protease activated receptor1 levels in patients with lung cancer. Erturk K; Tastekin D; Bilgin E; Tas F; Disci R; Duranyildiz D Eur Rev Med Pharmacol Sci; 2016; 20(2):243-9. PubMed ID: 26875892 [TBL] [Abstract][Full Text] [Related]
16. Increased serum level of epidermal growth factor receptor (EGFR) is associated with poor progression-free survival in patients with epithelial ovarian cancer. Tas F; Karabulut S; Serilmez M; Ciftci R; Duranyildiz D Cancer Chemother Pharmacol; 2014 Mar; 73(3):631-7. PubMed ID: 24477605 [TBL] [Abstract][Full Text] [Related]
17. Elevated circulating monocyte chemoattractant protein 1 (MCP-1/CCL-2) level may be an unfavorable predictive factor to platinum- and taxane-based combination chemotherapy in patients with gastric cancer. Tas F; Karabulut S; Serilmez M; Karabulut M; Duranyildiz D Cancer Chemother Pharmacol; 2016 Jan; 77(1):127-31. PubMed ID: 26499899 [TBL] [Abstract][Full Text] [Related]
18. Clinical Signifıcance of Serum Ykl-40 (Chitinase-3-Like-1 Protein) as a Biomarker in Melanoma: an Analysis of 112 Turkish Patients. Erturk K; Tas F; Serilmez M; Bilgin E; Yasasever V Asian Pac J Cancer Prev; 2017 May; 18(5):1383-1387. PubMed ID: 28612591 [TBL] [Abstract][Full Text] [Related]
19. Elevated erythrocyte sedimentation rate is associated with metastatic disease and worse survival in patients with cutaneous malignant melanoma. Tas F; Erturk K Mol Clin Oncol; 2017 Dec; 7(6):1142-1146. PubMed ID: 29285390 [TBL] [Abstract][Full Text] [Related]
20. Expression of protease-activated receptors 1 and 2 in melanocytic nevi and malignant melanoma. Massi D; Naldini A; Ardinghi C; Carraro F; Franchi A; Paglierani M; Tarantini F; Ketabchi S; Cirino G; Hollenberg MD; Geppetti P; Santucci M Hum Pathol; 2005 Jun; 36(6):676-85. PubMed ID: 16021575 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]